SMTL ID : 4gk2.1

Human EphA3 Kinase domain in complex with ligand 66

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x L66: 7-(5-hydroxy-2-methylphenyl)-8-(2-methoxyphenyl)-1-methyl-1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione(Non-covalent)

L66.1: 15 residues within 4Å: Chain A: V.41, V.49, A.65, K.67, E.84, M.88, T.113, E.114, Y.115, M.116, G.119, R.164, L.167, S.177, D.178 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.49, A:A.65, A:K.67, A:K.67, A:T.113 Hydrogen bonds: A:E.84, A:M.116, A:M.116, A:S.177, A:D.178 Water bridges: A:K.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lafleur, K. et al., Optimization of Inhibitors of the Tyrosine Kinase EphB4. 2. Cellular Potency Improvement and Binding Mode Validation by X-ray Crystallography. J.Med.Chem. (2013)

Release Date

2013-01-23

Peptides

EPH receptor A3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

EPH receptor A3

Related Entries With Identical Sequence